Scientists Discover an Alternative to Ozempic That Could Revolutionize Weight Loss

Weight loss methods are getting more complicated every year but what if the answer came from somewhere completely unexpected?

Researchers at the University of Colorado, Stanford Medicine, and Baylor University have been studying a surprising possibility. Their work focuses on a compound found in python blood that also exists in tiny amounts in human urine.

The compound, called pTOS, is produced by gut bacteria and rises dramatically in a python’s body after it eats.

When scientists tested this molecule on obese mice, the results were fascinating. The mice naturally ate less and began to lose weight.

Of course, humans are not mice or snakes. Dr. Jonathan Long, a co-author of the study and associate professor of pathology at Stanford University, made that clear. Still, he believes studying these animals could help researchers better understand the molecules and pathways that influence human metabolism.

So Why Pythons?

These snakes are known for eating prey nearly their own size, then going months or years without another meal. However, what is interesting is that they manage to maintain their muscle and overall health levels during these long periods without food.

When researchers looked closer, they found that pTOS did not affect energy use or organ size in mice. Instead, it directly influenced appetite and feeding behavior.

After 28 days, the lab mice had lost around 9 percent of their body weight.

What Makes This Different From Current Weight Loss Drugs?

This is where things get especially interesting. Current weight loss drugs like Ozempic work by slowing down how quickly the stomach empties, which can lead to side effects like nausea and indigestion. pTOS appears to work differently by targeting the part of the brain that controls hunger.

That difference could make it a much more tolerable option if it works the same way in humans.

It is still early and the compound has not been tested in people yet. Even so, researchers are optimistic, especially since small amounts of pTOS already exist in the human body, so it is assumed to be safe.

Beyond Weight Loss

The team has already launched a company called Arkana Therapeutics and they have plans to develop other treatments based on this discovery.

They are also looking beyond weight loss. One area of interest is age-related muscle loss, known as sarcopenia, which currently has no cure. If this research leads somewhere, it could open the door to entirely new ways of treating metabolic conditions.

Professor Leslie Leinwand, a co-author of the study and biologist at the University of Colorado Boulder promised that this is just the beginning. “We’re not stopping with just this one metabolite,” she said. “There’s a lot more to be learned.”

Related: Why You’re Not Losing Weight Eating 'Healthy,' According to Dietitians